Fennec Pharmaceuticals Inc (FENC)

Fennec Pharmaceuticals Inc (FENC) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $358M; returns 1 day -2.3%, 1 week +1.0%, 1 year +12.5%.

Fennec Pharmaceuticals Inc. is a commercial-stage specialty pharmaceutical company focused on oncology supportive care. Its core business revolves around the development and commercialization of PEDMARK (sodium thiosulfate injection) in the United States and PEDMARQSI in Europe and the UK.

Groups FENC belongs to

• Healthcare
• Pharmaceuticals
• Oncology
• Commercial Stage
• Commercial Stage Biotech
• Biotechnology
• Healthcare Services
• Unmet Medical Needs

FENC financial model: income statement, cash flow and balance sheet